city Sanofi covid-19 vaccine city Sanofi

Sanofi and Translate Bio to develop mRNA vaccine for Covid-19

Reading now: 897
www.pharmaceutical-technology.com

Visit our Covid-19 microsite for the latest coronavirus news, analysis and updates Sanofi vaccines division Sanofi Pasteur has partnered with Translate Bio for the development of a messenger RNA (mRNA) vaccine against Covid-19.

Translate Bio has already started the production of several mRNA constructs. The company will leverage its mRNA platform for the discovery, design and manufacture of SARS-CoV-2 vaccine candidates.

Sanofi will contribute via its vaccine expertise and external research networks support. The aim is to progress vaccine candidates for further development.

Translate Bio has created 100g single-batch production using its mRNA therapeutics platform, while a separate manufacturing space is being built by a contract

Read more on pharmaceutical-technology.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA